6533b7cffe1ef96bd1257fc3

RESEARCH PRODUCT

Compliance to therapy with Dapoxetine in comparison to a conventional selective serotonin reuptake inhibitor (Citalopram) in 118 patients with premature ejaculation.

Carlo PavoneDaniela AbbadessaGiovanna ScadutoGiovanni CaruanaGiuseppa GambinoVincenzo SerrettaCristina Scalici Gesolfo

subject

Dapoxetine SSRI Premaure Ejaculation complianceSettore MED/24 - Urologia

description

Premature Ejaculation (PE) is a sexual dysfunction that concern 20-30% of the male population. Dapoxetine is a new serotonine re-uptake inhibitor (SSRI)specific for PE treatment.Aim of the study is to assess compliance and effectiveness of the treatment with dapoxetine compared to the treatment with citalopram (a classic SSRI used to treat PE).

yearjournalcountryeditionlanguage
2013-01-01
http://hdl.handle.net/10447/87983